Diabetes Mellitus (DM) is a global health challenge. One in 11 adults (20-79 years) were reported to have DM by the International Diabetes Federation (IDF) in 2019, and this proportion is on the rise as society changes and the population ages. [1] DM complications include a series of problems, such as nephropathy, retinopathy, and coronaryartery …
HbA1c: The Core Marker of Diabetes Mellitus Management Read More »
4 liquid samples (minimum 0,3 ml) of human plasma. 4 surveys per year. Analytical parameters Instructions for Use IFU_COVID_2021_01-02 Brochure ESfEQA_Brochure_anti-SARS-CoV
SARS-CoV-2 Molecular 3 liquid or lyophilized samples (minumum 1 mL) containing human epithelial cells or fibroblasts as control for positive extraction and amplification. Virus-positive samples contain the whole genome of inactivated SARS-CoV-2, thus covering all possible gene targets used in different NAT/PCR assays. 4 surveys per year Analytical parameters SARS-CoV-2 RNA (qualitative), SARS-CoV-2 RNA (quantitative) …
As of January 26th, 2021, the coronavirus disease 2019 (COVID-19) pandemic has affected over 100 million people worldwide. Vaccination would help improve the situation in future. However, at this time, identifying patients at highest risk for severe disease is important. In order to facilitate early intervention and to manage local hospital resources to mitigate the …
Have You Noticed the Changes of Red Blood Cells in COVID-19? Read More »
Global COVID-19 Situation As of 31 March 2021 Source:World Health Organization Currently there are no known safe and effective treatments for the most severe symptoms of COVID-19. The lack of effective treatments means that vaccines are the only way to end the devastating impact of the pandemic. Fortunately, several different types of vaccines have already …
SARS-CoV-2 Neutralizing Antibodies Immunoassay Detection Episode 1: S- RBD IgG Read More »